Capital AllocationWide moat

Berkshire Hathaway (BRK.B) — moat facet

Cash flows from dozens of businesses to one desk, and from that desk to wherever it earns the most — the compounding machine itself.

Berkshire's rarest and most valuable asset is not a factory or a brand but a way of thinking — a genuine, hard-won judgment about where a dollar will earn its best return. This is worth pausing on, because it is the single quality that separates Berkshire from the ordinary run of large companies. Most corporations are prisoners of their own industry: a railroad reinvests in railroading, a retailer in retailing, good years and bad, because that is the only thing management knows how to do. Berkshire is free of that prison entirely.

Where capital went, first half of 2026 ($B)Stocks bought$39.4BStocks sold$27.8BBusinesses bought$9.7BOwn shares repurchased$4.4BCash flow statement, Berkshire Form 10-Q, June 2026
Abel's first half used every outlet Berkshire has: stocks, companies and its own shares.

Cash flows to the center from dozens of businesses, and from that center it can be deployed into whatever offers the best return at the time — buying a whole company outright, purchasing a stake in a public one, or, when nothing else is attractive, repurchasing Berkshire's own shares. That flexibility is an enormous structural advantage, because it means every dollar the enterprise generates can seek out its highest and best use rather than being poured back, by default, into whatever business happened to produce it. Capital, at Berkshire, goes where it is treated best.

The discipline to exercise that flexibility well is even rarer than the flexibility itself. The willingness to sit in cash and do nothing — to let the money pile up, unglamorously, while the market runs hot and rivals chase overpriced deals — is one of the hardest things in all of finance, because it invites criticism and appears, to the impatient, like a failure to act. Yet it is exactly that patience that lets Berkshire strike hard when a genuine bargain finally appears, often in a crisis when cash is scarce and the bargains are greatest. Waiting for the fat pitch is itself a competitive edge.

What makes it all possible is a horizon measured in decades rather than quarters. Berkshire can buy a business or a stock and hold it for twenty years, indifferent to what the market does next month, and it can therefore act on value that will only be realized over a very long span — value that a manager judged on the next earnings report would never dare to reach for. Thinking in decades while others think in quarters is not a slogan at Berkshire; it is the operating reality that shapes every major decision.

Put together — cash flowing to a single wise center, freedom to deploy it anywhere, the discipline to wait for the right moment, and a horizon long enough to be patient — this is a compounding advantage that grows more valuable the longer it operates. Great capital allocation, exercised consistently over many decades, is perhaps the most powerful force in all of business, precisely because so few institutions are built to practice it. Berkshire was built for little else — sixty-plus acquired businesses and $365.5 billion of cash and Treasury bills at the end of June 2026 attest to it.12

Moat trajectory: Narrowing

Narrowing — this is where the transition bites hardest. The plumbing that carries cash to a single center is fully intact, but the moat here was never the plumbing; it was the judgment waiting at the center, and for sixty years that judgment was Buffett's. As of 2026 the pen has passed to Greg Abel, and no successor arrives with a six-decade record that cannot be inherited. The most likely outcome is competent, disciplined allocation earning respectable returns — a narrowing of the specific edge, from singular brilliance toward ordinary good sense. The source of the magic is the facet most exposed.

The number that tests this moat
Moat Explorer calc
Cash and Treasury bills, consolidated
$365.5B at 30 June 2026, from a record $397.4B at 31 March

The first fall in the pile under Abel came with OxyChem, $11.6B of net stock buying and $4.8B of buybacks. A pile back above $400B within a year would mean deployment stalled again.

How it's calculated: Consolidated cash and cash equivalents plus short-term U.S. Treasury Bills, gross of unsettled purchases: June 2026 35,096 + 324,905 + 5,513 (railroad, utilities and energy) = 365,514; March 2026 51,478 + 339,261 + 6,644 = 397,383.
Source: Berkshire Form 10-Q, quarter ended 30 June 2026; Form 10-Q, March 2026 ↗
Aspects of the moat
⚠ Threats to the moat
References
  1. ReportedBerkshire was built for little else — sixty-plus acquired businesses and $365.5 billion of cash and Treasury bills at the end of June 2026 attest to it.
    Berkshire Hathaway Form 10-Q, quarter ended 30 June 2026 - after-tax earnings (underwriting $1,731M vs $1,992M, insurance investment income $3,059M vs $3,367M, BNSF $1,558M vs $1,466M, BHE $891M vs $702M, manufacturing, service and retailing $4,470M vs $3,601M, investment gains $12,684M, net earnings $25,667M); GEICO pre-tax underwriting $994M vs $1,821M, combined ratio 91.2% vs 83.5%; Reinsurance $913M vs $650M; float $177.5B; insurance and other cash and Treasury Bills net $359.2B; consolidated cash $35,096M + $324,905M + $5,513M; equity securities $323.8B; H1 purchases of equities $39.4B and sales $27.8B; acquisitions of businesses net of cash $9.7B; $4.8B of treasury stock acquired in H1, most in Q2; OxyChem about $9.4B on 2 January; Taylor Morrison agreed 31 May at $72.50 a share, about $6.8B, closed 24 July; notes payable of insurance and other $43.3B; shareholders' equity $747.9B; BNSF revenue $6,601M vs $5,769M, fuel $1,173M vs $698M; BHE revenue $6,735M vs $6,418M; investment income down 9.1% on lower interest rates — Q2 2026 · publ. August 2026 · source ↗
  2. Moat Explorer calcBerkshire was built for little else — sixty-plus acquired businesses and $365.5 billion of cash and Treasury bills at the end of June 2026 attest to it.
    Moat Explorer calculation from Berkshire's Forms 10-K FY2016-FY2025 and 10-Qs for Q1 and Q2 2026: operating earnings = net earnings less after-tax investment gains and the 2025 impairments (FY2023 $37,350M, FY2024 $47,437M, FY2025 $44,486M; Q2 2026 $12,983M vs $11,160M; H1 2026 $24,329M vs $20,801M); consolidated cash and Treasury Bills $397.4B (31 March 2026) and $365.5B (30 June 2026); underwriting as a share of float; OxyChem at 2.6% of the cash pile; five-line after-tax earnings sums — 2016 to Q2 2026 · publ. 2026-09-23 · source ↗
Sources
Generated September 23, 2026